![](/img/cover-not-exists.png)
PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
Han, S., Shi, L.W., SUN, H.K., Dong, P.X., Zheng, L.Y.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.595
Date:
May, 2019
File:
PDF, 703 KB
2019